CN102550541A - Organ vitrification freezing and preserving fluid - Google Patents
Organ vitrification freezing and preserving fluid Download PDFInfo
- Publication number
- CN102550541A CN102550541A CN2010106013581A CN201010601358A CN102550541A CN 102550541 A CN102550541 A CN 102550541A CN 2010106013581 A CN2010106013581 A CN 2010106013581A CN 201010601358 A CN201010601358 A CN 201010601358A CN 102550541 A CN102550541 A CN 102550541A
- Authority
- CN
- China
- Prior art keywords
- freezing
- organ
- preserving
- organs
- acetamide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
The invention relates to the field of medical organ preservation and more particularly discloses a vitrification freezing and preserving fluid for preserving organs for a long term. The organ vitrification freezing and preserving fluid is characterized by comprising dimethyl sulfoxide, acetamide, glycerol, ethylene glycol, propylene glycol, cane sugar, polyethylene glycol and the like, wherein the concentrations of the dimethyl sulfoxide, the acetamide, the glycerol, the ethylene glycol, the propylene glycol and the cane sugar are 0.1-6 mol/L; the concentration of the polyethylene glycol is 1-20 mmol/L; and the pH value is in a range from 5.0 to 8.0. By implementing the vitrification preserving fluid for preserving organs, provided by the invention, the preserving fluid is in a glassy state rather than forming ice crystal in the cooling and freezing process to protect the tissue morphology and structure completeness, completely suppresses energy metabolism of tissue cells under a freezing condition and recovers biological functions of organs after anabiosis. The organ vitrification freezing and preserving fluid, disclosed by the invention, can be used for freezing and preserving kidney and also can be further widely applied to freezing and preserving of other organs for a long term for scientific research and clinic application.
Description
Technical field
Kidney is the complicated organ of function in the human body, can only {in vitro} conservation under 4 ℃ of perfusion conditions maximum 50 hours.Will be for a long time even forever preserve kidney, must further reduce storage temperature, suppress histiocytic metabolic rate, even cellular metabolism is stopped fully.Kidney if can be preserved at suitable long period under refrigeration, transplants after when needed that the confession kidney employing of freezing preservation is the suitable means " recovery " again, will open up a brand-new prospect for clinical transplantation work.
Freezing and storing method is considered to realize the desirable approach of organ long preservation; Key of problem is that the organ volume is bigger; Ice crystal forms inside and outside in cooling and rewarming process, being difficult to overcome cell; Can not avoid simultaneously the damage of machinery, chemistry, osmotic pressure and biology aspect, so the frozen problem of larger volume organ is still unresolved so far.Vitrifying (Vitrification) is meant that liquid changes the solidification process of amorphous state (glassy state) into.Relation between the glassy solids molecule and the obviously difference of liquid nothing do not form ice crystal, thereby are a kind of desirable freezing preservation approach in the cooling refrigerating process.
Background technology
In the recent period, freezing preservation cell, sperm, embryo even ovary tissue are successively achieved success, but the freezing preservation of complex organ such as kidney but still is a difficult problem that does not break through as yet.The world today along with the continuous increase of kidney transplant technology rapid development and nephrotic's quantity, presses for a large amount of kidneys and stocks and supply.Clinical transplantation is with supplying kidney all preserving more than 0 ℃ at present, though the method comparative maturity, easy, the holding time is very limited.Though Chinese scholars sets about prolonging the kidney holding time from improving sides such as preserving liquid level and conserving appliance; Or in the limited holding time, improve tissue matching and work; Supply the reasonable utilization rate of kidney and the long-term surviving rate after the transplanting with raising, but still can not satisfy clinical demand.In addition, under the situation that donor organ lacks at home, owing to join type, patient's condition is not inconsistent and reasons such as region also can cause certain organ wasting of resources.Can in a country and even All Around The World scope, share human leucocyte antigen (HLA) (HLA) and join the kidney that type coincide; Make each receptor can both in time obtain optimized confession kidney? For Utopian like this hope; Have only through improving kidney preservation technology; Prolong confession kidney holding time to several months even several years, and set up " organ storehouse " (Organ Bank) and could finally realize.
Summary of the invention
Organ glass freezing according to the invention is preserved liquid; Form by compositions such as dimethyl sulfoxide (DMSO), acetamide, glycerine, ethylene glycol, propane diols, sucrose, polyethylene glycol; Dimethyl sulfoxide (DMSO), acetamide, glycerine, ethylene glycol, propane diols, sucrose concentration are 0.1-6mol/L; Polyethylene glycol concentration is 1-20mmol/L, and the pH value scope is 5.0-8.0.Glass freezing is preserved liquid solution in the cooling refrigerating process and is glassy state, does not form ice crystal, avoids or reduce the freezing infringement of cell, can protect cell structure and shape integrity, suppresses histiocytic energy metabolism simultaneously fully.Metabolic activity in cells is restored after suitable means recovery, can bring into play biological function again.Organ glass freezing according to the invention is preserved liquid, can be used for the freezing preservation (200--30 ℃) of kidney, and the long-term frozen that also can be applicable to other organs (liver, heart etc.) is preserved.
Embodiment
To preserve the perfusion kidney through organ glass freezing according to the invention, be cooled to-80 ℃, change profound hypothermia refrigerator or liquid nitrogen long preservation over to.Be warming up to 4 ℃ during the organ recovery, wash-out is preserved laggard line correlation morphology of liquid and function assessment inspection.
Preserve liquid at-80 ℃ of new zealand white rabbit kidneys of preserving for 2 weeks through organ glass freezing according to the invention, general form is not seen obvious freezing infringement, skin medullary substance clear in structure; The interior capillary button loop of glomerulus is complete under the light microscope; The slight swelling of renal cells, ultra microstructures such as glomerular filtration membrane, sertoli cell and mesangial cell are clear under the electron microscope, and the nuclei dyeing chromaticness is dense; Kytoplasm inner cell organ number is normal; Epithelial cell chamber face brush border microvillus marshalling, vascular endothelial cell and elastic membrane are complete, and demonstration kidney tissue morphology after freezing preservation is not seen obvious destruction.
Preserve liquid at-80 ℃ of new zealand white rabbit kidneys of preserving for 2 weeks through organ glass freezing according to the invention; Carry out phenolsulfonphthalein excretion test (PSP test), indicarminum measuring renal tubular function behind the ex vivo perfusion; PSP15 minute and 120 minutes excretion amounts are all near normal value (25%; 55%), sees blue urine at once after the indicarminum perfusion and discharge, show that kidney has the excretion function through freezing preservation metanephric tubule.
Preserve liquid at-80 ℃ of beasle dog kidneys of preserving for 2 weeks through organ glass freezing according to the invention; The autotransplantation of kidney postoperative carried out CDFI, emission single photon computed tomography (ECT) and the inspections such as (IVP) of vein secretion radiography in 1 month; Blood flow passes through in the color ultra visible transplanting kidney, and IVP and ECT show that renal secretion/filtering function continues to exist.
Claims (6)
1. an organ glass freezing is preserved liquid, it is characterized in that, comprises compositions such as dimethyl sulfoxide (DMSO), acetamide, glycerine, ethylene glycol, propane diols, sucrose, polyethylene glycol.
2. preservation liquid according to claim 1 is characterized in that dimethyl sulfoxide (DMSO), acetamide, glycerine, ethylene glycol, propane diols, sucrose concentration are 0.1-6mol/L, and polyethylene glycol concentration is 1-20mmol/L, and the pH value scope is 5.0-8.0.
3. requiring 1 described preservation liquid according to economic rights, it is characterized in that, storage temperature is-200--30 degree centigrade.
4. according to the arbitrary described preservation liquid of claim 1 to 3, it is characterized in that described organ is kidney, liver, heart, lungs, skin or limbs etc.
5. an organ store method comprises organ is put into preservation liquid, it is characterized in that, comprises compositions such as dimethyl sulfoxide (DMSO), acetamide, glycerine, ethylene glycol, propane diols, sucrose, polyethylene glycol in the said preservation liquid.
6. store method according to claim 5 is characterized in that, organ is carried out glass freezing preserve.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201010601358.1A CN102550541B (en) | 2010-12-23 | 2010-12-23 | Organ vitrificated cryopreserration liquid |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201010601358.1A CN102550541B (en) | 2010-12-23 | 2010-12-23 | Organ vitrificated cryopreserration liquid |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102550541A true CN102550541A (en) | 2012-07-11 |
CN102550541B CN102550541B (en) | 2016-02-17 |
Family
ID=46398195
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201010601358.1A Active CN102550541B (en) | 2010-12-23 | 2010-12-23 | Organ vitrificated cryopreserration liquid |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102550541B (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104585165A (en) * | 2015-02-24 | 2015-05-06 | 陈德琼 | Human organ freezing protective solution |
CN104904707A (en) * | 2015-05-29 | 2015-09-16 | 广州赛莱拉干细胞科技股份有限公司 | Composition, application of composition, vitrification cryopreserved agent of placenta and preparation method |
CN105241726A (en) * | 2015-09-14 | 2016-01-13 | 黄小军 | Immunohistochemical staining method and applications of immunohistochemical staining method in cervical tumorous lesion screening |
CN107236340A (en) * | 2017-05-22 | 2017-10-10 | 安徽宏远职业卫生技术服务有限公司 | A kind of cuvette store method |
WO2018118799A1 (en) * | 2016-12-20 | 2018-06-28 | Tissue Testing Technologies Llc | Ice-free preservation of large volume tissue samples for viable, functional tissue banking |
CN111657267A (en) * | 2020-06-17 | 2020-09-15 | 科瑞百奥泰州生物技术有限公司 | Ice-free crystal frozen preservation solution and freezing method for preservation of cartilage, tendon and meniscus |
CN117717066A (en) * | 2024-02-04 | 2024-03-19 | 广东海洋大学 | Embryo preservation solution, cryopreservation method thereof and application of embryo preservation solution in cryopreservation of Babylonia embryos |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002032225A2 (en) * | 2000-10-19 | 2002-04-25 | Organ Recovery Systems | Method of cryopreservation of tissues or organs other than a blood vessel by vitrification |
CN1986780A (en) * | 2006-12-14 | 2007-06-27 | 宁夏医学院 | New-type of vetrifying solution |
CN101037667A (en) * | 2007-02-09 | 2007-09-19 | 浙江大学 | Ultra-low temperature preservation solution for animal cells and preserving method |
CN101253856A (en) * | 2008-04-11 | 2008-09-03 | 中山大学 | Vitrification frozen stock solution |
WO2010096821A2 (en) * | 2009-02-23 | 2010-08-26 | Cell & Tissue Systems, Inc. | Method for ice-free cryopreservation of tissue |
-
2010
- 2010-12-23 CN CN201010601358.1A patent/CN102550541B/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002032225A2 (en) * | 2000-10-19 | 2002-04-25 | Organ Recovery Systems | Method of cryopreservation of tissues or organs other than a blood vessel by vitrification |
CN1986780A (en) * | 2006-12-14 | 2007-06-27 | 宁夏医学院 | New-type of vetrifying solution |
CN101037667A (en) * | 2007-02-09 | 2007-09-19 | 浙江大学 | Ultra-low temperature preservation solution for animal cells and preserving method |
CN101253856A (en) * | 2008-04-11 | 2008-09-03 | 中山大学 | Vitrification frozen stock solution |
WO2010096821A2 (en) * | 2009-02-23 | 2010-08-26 | Cell & Tissue Systems, Inc. | Method for ice-free cryopreservation of tissue |
Non-Patent Citations (1)
Title |
---|
胡军祥 等: "动物胚胎的玻璃化冻存", 《科技通报》 * |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104585165A (en) * | 2015-02-24 | 2015-05-06 | 陈德琼 | Human organ freezing protective solution |
CN104904707A (en) * | 2015-05-29 | 2015-09-16 | 广州赛莱拉干细胞科技股份有限公司 | Composition, application of composition, vitrification cryopreserved agent of placenta and preparation method |
CN105241726A (en) * | 2015-09-14 | 2016-01-13 | 黄小军 | Immunohistochemical staining method and applications of immunohistochemical staining method in cervical tumorous lesion screening |
WO2018118799A1 (en) * | 2016-12-20 | 2018-06-28 | Tissue Testing Technologies Llc | Ice-free preservation of large volume tissue samples for viable, functional tissue banking |
CN110545665A (en) * | 2016-12-20 | 2019-12-06 | 组织测试技术有限公司 | Ice-free preservation of large volume tissue samples for live functional tissue banks |
JP2020504725A (en) * | 2016-12-20 | 2020-02-13 | ティシュー テスティング テクノロジーズ エルエルシーTissue Testing Technologies Llc | Ice-free storage of large volume tissue samples for practical and functional tissue banking |
US11246308B2 (en) * | 2016-12-20 | 2022-02-15 | Tissue Testing Technologies Llc | Ice-free preservation of large volume tissue samples for viable, functional tissue banking |
CN107236340A (en) * | 2017-05-22 | 2017-10-10 | 安徽宏远职业卫生技术服务有限公司 | A kind of cuvette store method |
CN111657267A (en) * | 2020-06-17 | 2020-09-15 | 科瑞百奥泰州生物技术有限公司 | Ice-free crystal frozen preservation solution and freezing method for preservation of cartilage, tendon and meniscus |
CN111657267B (en) * | 2020-06-17 | 2021-02-02 | 科瑞百奥泰州生物技术有限公司 | Ice-free crystal frozen preservation solution and freezing method for preservation of cartilage, tendon and meniscus |
CN117717066A (en) * | 2024-02-04 | 2024-03-19 | 广东海洋大学 | Embryo preservation solution, cryopreservation method thereof and application of embryo preservation solution in cryopreservation of Babylonia embryos |
CN117717066B (en) * | 2024-02-04 | 2024-04-26 | 广东海洋大学 | Embryo preservation solution, cryopreservation method thereof and application of embryo preservation solution in cryopreservation of Babylonia embryos |
Also Published As
Publication number | Publication date |
---|---|
CN102550541B (en) | 2016-02-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102550541A (en) | Organ vitrification freezing and preserving fluid | |
EP2398316B1 (en) | Method for ice-free cryopreservation of tissue | |
CN102144629A (en) | Organ cryopreservation fluid | |
AU2002211792B2 (en) | Method of cryopreservation of tissues or organs other than a blood vessel by vitrification | |
JP6099808B2 (en) | Vitrification freezing carrier of biological sample and use thereof | |
CN101720753A (en) | Cryopreservation solution of tissue engineering products and application method thereof | |
CN102428911A (en) | Cryogenic storing protection liquid for human umbilical cord Wharton's jelly tissue block | |
Wang et al. | Cryopreservation of tissue-engineered dermal replacement in Me2SO: Toxicity study and effects of concentration and cooling rates on cell viability | |
CN109329271A (en) | A kind of clinical mescenchymal stem cell freezen protective liquid and preparation method thereof | |
CN101971799A (en) | Freezing storage protective solution for human umbilical Wharton's jelly tissue block | |
CN105230610B (en) | A kind of freezen protective liquid and its preparation method and application | |
CN104145943A (en) | Cryopreservation protection liquid for Wharton jelly tissues of human umbilical cord and preparation and application of cryopreservation protection liquid | |
AU2002211792A1 (en) | Method of cryopreservation of tissues or organs other than a blood vessel by vitrification | |
CN104488853A (en) | Bovine embryo vitrification freezing tube swinging thawing and direct transplanting method | |
Wowk | How cryoprotectants work | |
ES2949014T3 (en) | Use of a solution comprising PEG for the preservation of stem cells | |
CN109699636A (en) | A kind of glass freezing and defreezing method of embryo | |
CN104585165A (en) | Human organ freezing protective solution | |
CN115152740A (en) | Long-term pig tissue preservation solution and using method thereof | |
Toner et al. | Storage and translational issues in reparative medicine | |
CN100463963C (en) | Freeze preservating method for domestic pig skin tissue | |
ITPI20000020A1 (en) | SACCHAROSE OONCENTRATIONS AND DURATION OF THE EXPOSURE OF THE Oocyte LOADING SOLUTIONS IN THE CRYOPRESERVATION PROCEDURE | |
CN103355285B (en) | Cryopreservation method of tobacco leaf callus cell | |
CN103348968A (en) | Ice-temperature storage method of transplanted kidney and organs | |
CN111374123A (en) | Use method of neutral amino acid as cell cryoprotectant and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
DD01 | Delivery of document by public notice |
Addressee: Pan Feng Document name: the First Notification of an Office Action |
|
DD01 | Delivery of document by public notice |
Addressee: Liu Di Document name: Notification to Go Through Formalities of Registration |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
DD01 | Delivery of document by public notice |
Addressee: Pan Feng Document name: Notification of Passing Examination on Formalities |